View in EDS HTML Full Text PDF Full Text

Risankizumab versus Deucravacitinib in Adults With Moderate Plaque Psoriasis: 16-Week Results from the Phase 4 IMMpactful Trial.

Saved in:
Bibliographic Details
Title: Risankizumab versus Deucravacitinib in Adults With Moderate Plaque Psoriasis: 16-Week Results from the Phase 4 IMMpactful Trial.
Authors: Magnolo N; Department of Dermatology, University Hospital Muenster, Von-Esmarch-Str. 58, 48149, Münster, Germany. nina.magnolo@ukmuenster.de., Soung J; Department of Dermatology, Southern California Dermatology, Santa Ana, CA, USA.; Division of Dermatology, Harbor University of California Los Angeles, Torrance, CA, USA., Frew J; The Skin Hospital, Sydney, NSW, Australia.; Department of Dermatology, Liverpool Hospital, Sydney, NSW, Australia.; University of New South Wales, Sydney, NSW, Australia., Costanzo A; Dermatology Unit, Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.; Humanitas Clinical and Research Center, Scientific Institute for Research, Hospitalization and Healthcare, Rozzano, Italy., Ruiz-Santiago H; Department of Dermatology, University of Puerto Rico School of Medicine, San Juan, Puerto Rico., Eyerich K; Department of Dermatology, Medical Center-University of Freiburg, Freiburg, Germany., Llamas-Velasco M; Dermatology Department, Hospital Universitario de La Princesa, Madrid, Spain., Bukhalo M; Arlington Dermatology, Ascension St. Alexius Medical Center, Hoffman Estates, IL, USA., Sivamani RK; Integrative Skin Science and Research, Sacramento, CA, USA., Moore A; Baylor University Medical Center, Dallas, TX, USA.; Arlington Research Center, Arlington, TX, USA.; Arlington Center for Dermatology, Arlington, TX, USA., Wu T; AbbVie Inc., North Chicago, IL, USA., Xie J; AbbVie Inc., North Chicago, IL, USA., Patel M; AbbVie Inc., North Chicago, IL, USA., Ashley D; AbbVie Inc., North Chicago, IL, USA., Kaplan B; AbbVie Inc., North Chicago, IL, USA., Stakias V; AbbVie Inc., North Chicago, IL, USA., Espaillat R; AbbVie Inc., North Chicago, IL, USA., Warren RB; Dermatology Centre, Northern Care Alliance NHS Foundation Trust & Division of Musculoskeletal and Dermatological Sciences, Manchester NIHR Biomedical Research Centre, Manchester Academic Health Science Centre, University of Manchester, Machester, UK.
Source: Dermatology and therapy [Dermatol Ther (Heidelb)] 2026 Jul; Vol. 16 (7), pp. 3415-3429. Date of Electronic Publication: 2026 May 17.
Publication Type: Journal Article
Journal Info: Publisher: Springer Healthcare Communications Country of Publication: Switzerland NLM ID: 101590450 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2193-8210 (Print) NLM ISO Abbreviation: Dermatol Ther (Heidelb) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42143644
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Risankizumab versus Deucravacitinib in Adults With Moderate Plaque Psoriasis: 16-Week Results from the Phase 4 IMMpactful Trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Magnolo+N%22">Magnolo N</searchLink>; Department of Dermatology, University Hospital Muenster, Von-Esmarch-Str. 58, 48149, Münster, Germany. nina.magnolo@ukmuenster.de.<br /><searchLink fieldCode="AU" term="%22Soung+J%22">Soung J</searchLink>; Department of Dermatology, Southern California Dermatology, Santa Ana, CA, USA.; Division of Dermatology, Harbor University of California Los Angeles, Torrance, CA, USA.<br /><searchLink fieldCode="AU" term="%22Frew+J%22">Frew J</searchLink>; The Skin Hospital, Sydney, NSW, Australia.; Department of Dermatology, Liverpool Hospital, Sydney, NSW, Australia.; University of New South Wales, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Costanzo+A%22">Costanzo A</searchLink>; Dermatology Unit, Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.; Humanitas Clinical and Research Center, Scientific Institute for Research, Hospitalization and Healthcare, Rozzano, Italy.<br /><searchLink fieldCode="AU" term="%22Ruiz-Santiago+H%22">Ruiz-Santiago H</searchLink>; Department of Dermatology, University of Puerto Rico School of Medicine, San Juan, Puerto Rico.<br /><searchLink fieldCode="AU" term="%22Eyerich+K%22">Eyerich K</searchLink>; Department of Dermatology, Medical Center-University of Freiburg, Freiburg, Germany.<br /><searchLink fieldCode="AU" term="%22Llamas-Velasco+M%22">Llamas-Velasco M</searchLink>; Dermatology Department, Hospital Universitario de La Princesa, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Bukhalo+M%22">Bukhalo M</searchLink>; Arlington Dermatology, Ascension St. Alexius Medical Center, Hoffman Estates, IL, USA.<br /><searchLink fieldCode="AU" term="%22Sivamani+RK%22">Sivamani RK</searchLink>; Integrative Skin Science and Research, Sacramento, CA, USA.<br /><searchLink fieldCode="AU" term="%22Moore+A%22">Moore A</searchLink>; Baylor University Medical Center, Dallas, TX, USA.; Arlington Research Center, Arlington, TX, USA.; Arlington Center for Dermatology, Arlington, TX, USA.<br /><searchLink fieldCode="AU" term="%22Wu+T%22">Wu T</searchLink>; AbbVie Inc., North Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Xie+J%22">Xie J</searchLink>; AbbVie Inc., North Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Patel+M%22">Patel M</searchLink>; AbbVie Inc., North Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Ashley+D%22">Ashley D</searchLink>; AbbVie Inc., North Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Kaplan+B%22">Kaplan B</searchLink>; AbbVie Inc., North Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Stakias+V%22">Stakias V</searchLink>; AbbVie Inc., North Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Espaillat+R%22">Espaillat R</searchLink>; AbbVie Inc., North Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Warren+RB%22">Warren RB</searchLink>; Dermatology Centre, Northern Care Alliance NHS Foundation Trust & Division of Musculoskeletal and Dermatological Sciences, Manchester NIHR Biomedical Research Centre, Manchester Academic Health Science Centre, University of Manchester, Machester, UK.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101590450%22">Dermatology and therapy</searchLink> [Dermatol Ther (Heidelb)] 2026 Jul; Vol. 16 (7), pp. 3415-3429. <i>Date of Electronic Publication: </i>2026 May 17.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Healthcare+Communications%22">Springer Healthcare Communications </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101590450 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2193-8210 (Print) <i>NLM ISO Abbreviation: </i>Dermatol Ther (Heidelb) <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42143644
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s13555-026-01779-x
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 3415
    Titles:
      – TitleFull: Risankizumab versus Deucravacitinib in Adults With Moderate Plaque Psoriasis: 16-Week Results from the Phase 4 IMMpactful Trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Magnolo N
      – PersonEntity:
          Name:
            NameFull: Soung J
      – PersonEntity:
          Name:
            NameFull: Frew J
      – PersonEntity:
          Name:
            NameFull: Costanzo A
      – PersonEntity:
          Name:
            NameFull: Ruiz-Santiago H
      – PersonEntity:
          Name:
            NameFull: Eyerich K
      – PersonEntity:
          Name:
            NameFull: Llamas-Velasco M
      – PersonEntity:
          Name:
            NameFull: Bukhalo M
      – PersonEntity:
          Name:
            NameFull: Sivamani RK
      – PersonEntity:
          Name:
            NameFull: Moore A
      – PersonEntity:
          Name:
            NameFull: Wu T
      – PersonEntity:
          Name:
            NameFull: Xie J
      – PersonEntity:
          Name:
            NameFull: Patel M
      – PersonEntity:
          Name:
            NameFull: Ashley D
      – PersonEntity:
          Name:
            NameFull: Kaplan B
      – PersonEntity:
          Name:
            NameFull: Stakias V
      – PersonEntity:
          Name:
            NameFull: Espaillat R
      – PersonEntity:
          Name:
            NameFull: Warren RB
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2026 Jul
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 2193-8210
          Numbering:
            – Type: volume
              Value: 16
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Dermatology and therapy
              Type: main
ResultId 1